nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—CYP2D6—Temsirolimus—kidney cancer	0.113	0.183	CbGbCtD
Phentermine—CYP1A2—Pazopanib—kidney cancer	0.0718	0.117	CbGbCtD
Phentermine—CYP2C9—Capecitabine—kidney cancer	0.0675	0.11	CbGbCtD
Phentermine—CYP2D6—Pazopanib—kidney cancer	0.0592	0.0962	CbGbCtD
Phentermine—CYP1A2—Erlotinib—kidney cancer	0.0513	0.0833	CbGbCtD
Phentermine—CYP2C9—Paclitaxel—kidney cancer	0.0423	0.0687	CbGbCtD
Phentermine—CYP2D6—Erlotinib—kidney cancer	0.0422	0.0686	CbGbCtD
Phentermine—CYP1A2—Sorafenib—kidney cancer	0.0417	0.0677	CbGbCtD
Phentermine—CYP2C9—Sorafenib—kidney cancer	0.0375	0.061	CbGbCtD
Phentermine—CYP2D6—Sorafenib—kidney cancer	0.0343	0.0558	CbGbCtD
Phentermine—CYP2D6—Vinblastine—kidney cancer	0.0339	0.0551	CbGbCtD
Phentermine—CYP2D6—Doxorubicin—kidney cancer	0.0208	0.0339	CbGbCtD
Phentermine—CYP1A2—urine—kidney cancer	0.00303	0.15	CbGeAlD
Phentermine—CYP2C9—urine—kidney cancer	0.00288	0.143	CbGeAlD
Phentermine—Pseudoephedrine—IL2—kidney cancer	0.00222	0.267	CrCbGaD
Phentermine—CYP2D6—urine—kidney cancer	0.00216	0.107	CbGeAlD
Phentermine—Ephedrine—ACHE—kidney cancer	0.00174	0.208	CrCbGaD
Phentermine—Chest pain—Temsirolimus—kidney cancer	0.00144	0.00572	CcSEcCtD
Phentermine—Hallucination—Everolimus—kidney cancer	0.00144	0.00571	CcSEcCtD
Phentermine—Cardiac failure—Gemcitabine—kidney cancer	0.00144	0.0057	CcSEcCtD
Phentermine—Cerebrovascular accident—Gemcitabine—kidney cancer	0.00143	0.00568	CcSEcCtD
Phentermine—Cardiac arrest—Vincristine—kidney cancer	0.00141	0.00557	CcSEcCtD
Phentermine—Oedema—Temsirolimus—kidney cancer	0.00138	0.00548	CcSEcCtD
Phentermine—Acute coronary syndrome—Sorafenib—kidney cancer	0.00138	0.00547	CcSEcCtD
Phentermine—Hypertension—Pazopanib—kidney cancer	0.00138	0.00546	CcSEcCtD
Phentermine—Myocardial infarction—Sorafenib—kidney cancer	0.00137	0.00544	CcSEcCtD
Phentermine—Chest pain—Pazopanib—kidney cancer	0.00136	0.00539	CcSEcCtD
Phentermine—Dry mouth—Pazopanib—kidney cancer	0.00133	0.00527	CcSEcCtD
Phentermine—Acute coronary syndrome—Sunitinib—kidney cancer	0.00133	0.00527	CcSEcCtD
Phentermine—Lacosamide—CA9—kidney cancer	0.00131	0.157	CrCbGaD
Phentermine—Oedema—Pazopanib—kidney cancer	0.0013	0.00517	CcSEcCtD
Phentermine—Insomnia—Temsirolimus—kidney cancer	0.00125	0.00496	CcSEcCtD
Phentermine—Cardiac failure—Paclitaxel—kidney cancer	0.0012	0.00477	CcSEcCtD
Phentermine—Cerebrovascular accident—Paclitaxel—kidney cancer	0.0012	0.00475	CcSEcCtD
Phentermine—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00119	0.00473	CcSEcCtD
Phentermine—Fatigue—Temsirolimus—kidney cancer	0.00119	0.00473	CcSEcCtD
Phentermine—Constipation—Temsirolimus—kidney cancer	0.00118	0.00469	CcSEcCtD
Phentermine—Tremor—Everolimus—kidney cancer	0.00118	0.00468	CcSEcCtD
Phentermine—Insomnia—Pazopanib—kidney cancer	0.00118	0.00467	CcSEcCtD
Phentermine—Lacosamide—CA2—kidney cancer	0.00118	0.141	CrCbGaD
Phentermine—Erectile dysfunction—Vincristine—kidney cancer	0.00118	0.00467	CcSEcCtD
Phentermine—Agitation—Everolimus—kidney cancer	0.00116	0.00459	CcSEcCtD
Phentermine—Dyspepsia—Pazopanib—kidney cancer	0.00115	0.00455	CcSEcCtD
Phentermine—MAOB—nephron tubule—kidney cancer	0.00115	0.0568	CbGeAlD
Phentermine—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00112	0.00446	CcSEcCtD
Phentermine—Acute coronary syndrome—Vincristine—kidney cancer	0.00112	0.00445	CcSEcCtD
Phentermine—Fatigue—Pazopanib—kidney cancer	0.00112	0.00445	CcSEcCtD
Phentermine—Myocardial infarction—Vincristine—kidney cancer	0.00112	0.00443	CcSEcCtD
Phentermine—Cardiac arrest—Paclitaxel—kidney cancer	0.00112	0.00443	CcSEcCtD
Phentermine—Palpitations—Everolimus—kidney cancer	0.00111	0.00442	CcSEcCtD
Phentermine—Abdominal pain—Temsirolimus—kidney cancer	0.00109	0.00433	CcSEcCtD
Phentermine—Hypertension—Vinblastine—kidney cancer	0.00109	0.00433	CcSEcCtD
Phentermine—Hypertension—Everolimus—kidney cancer	0.00109	0.00431	CcSEcCtD
Phentermine—Chest pain—Everolimus—kidney cancer	0.00107	0.00425	CcSEcCtD
Phentermine—Acute coronary syndrome—Gemcitabine—kidney cancer	0.00107	0.00422	CcSEcCtD
Phentermine—Myocardial infarction—Gemcitabine—kidney cancer	0.00106	0.0042	CcSEcCtD
Phentermine—Dry mouth—Everolimus—kidney cancer	0.00105	0.00416	CcSEcCtD
Phentermine—MAOB—renal system—kidney cancer	0.00104	0.0516	CbGeAlD
Phentermine—Chest pain—Erlotinib—kidney cancer	0.00103	0.0041	CcSEcCtD
Phentermine—Abdominal pain—Pazopanib—kidney cancer	0.00103	0.00408	CcSEcCtD
Phentermine—Oedema—Everolimus—kidney cancer	0.00103	0.00408	CcSEcCtD
Phentermine—Ephedrine—BCHE—kidney cancer	0.00102	0.122	CrCbGaD
Phentermine—Hallucination—Vincristine—kidney cancer	0.00102	0.00404	CcSEcCtD
Phentermine—MAOB—kidney—kidney cancer	0.00101	0.0499	CbGeAlD
Phentermine—Tachycardia—Everolimus—kidney cancer	0.001	0.00398	CcSEcCtD
Phentermine—Oedema—Erlotinib—kidney cancer	0.000992	0.00394	CcSEcCtD
Phentermine—Asthenia—Temsirolimus—kidney cancer	0.000992	0.00393	CcSEcCtD
Phentermine—Cardiac failure—Capecitabine—kidney cancer	0.000987	0.00392	CcSEcCtD
Phentermine—Cerebrovascular accident—Capecitabine—kidney cancer	0.000983	0.0039	CcSEcCtD
Phentermine—MAOB—cortex of kidney—kidney cancer	0.000981	0.0486	CbGeAlD
Phentermine—MAOA—nephron tubule—kidney cancer	0.000977	0.0485	CbGeAlD
Phentermine—Diarrhoea—Temsirolimus—kidney cancer	0.000946	0.00375	CcSEcCtD
Phentermine—Hypertension—Sorafenib—kidney cancer	0.000944	0.00374	CcSEcCtD
Phentermine—Asthenia—Pazopanib—kidney cancer	0.000934	0.00371	CcSEcCtD
Phentermine—MAOB—cardiac atrium—kidney cancer	0.000933	0.0462	CbGeAlD
Phentermine—Insomnia—Everolimus—kidney cancer	0.00093	0.00369	CcSEcCtD
Phentermine—Cardiac arrest—Capecitabine—kidney cancer	0.000916	0.00363	CcSEcCtD
Phentermine—Dizziness—Temsirolimus—kidney cancer	0.000914	0.00363	CcSEcCtD
Phentermine—Dry mouth—Sorafenib—kidney cancer	0.00091	0.00361	CcSEcCtD
Phentermine—Hypertension—Sunitinib—kidney cancer	0.000908	0.0036	CcSEcCtD
Phentermine—Dyspepsia—Everolimus—kidney cancer	0.000905	0.00359	CcSEcCtD
Phentermine—Insomnia—Erlotinib—kidney cancer	0.000897	0.00356	CcSEcCtD
Phentermine—Chest pain—Sunitinib—kidney cancer	0.000896	0.00355	CcSEcCtD
Phentermine—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000892	0.00354	CcSEcCtD
Phentermine—Diarrhoea—Pazopanib—kidney cancer	0.000891	0.00353	CcSEcCtD
Phentermine—MAOA—renal system—kidney cancer	0.000889	0.044	CbGeAlD
Phentermine—Gastrointestinal disorder—Everolimus—kidney cancer	0.000888	0.00352	CcSEcCtD
Phentermine—Myocardial infarction—Paclitaxel—kidney cancer	0.000887	0.00352	CcSEcCtD
Phentermine—Fatigue—Everolimus—kidney cancer	0.000886	0.00352	CcSEcCtD
Phentermine—Constipation—Vinblastine—kidney cancer	0.000883	0.0035	CcSEcCtD
Phentermine—Constipation—Everolimus—kidney cancer	0.000879	0.00349	CcSEcCtD
Phentermine—Vomiting—Temsirolimus—kidney cancer	0.000879	0.00349	CcSEcCtD
Phentermine—Dry mouth—Sunitinib—kidney cancer	0.000876	0.00348	CcSEcCtD
Phentermine—Dyspepsia—Erlotinib—kidney cancer	0.000873	0.00346	CcSEcCtD
Phentermine—Rash—Temsirolimus—kidney cancer	0.000871	0.00346	CcSEcCtD
Phentermine—Dermatitis—Temsirolimus—kidney cancer	0.000871	0.00345	CcSEcCtD
Phentermine—Headache—Temsirolimus—kidney cancer	0.000866	0.00343	CcSEcCtD
Phentermine—SLC6A2—gonad—kidney cancer	0.000865	0.0429	CbGeAlD
Phentermine—Dizziness—Pazopanib—kidney cancer	0.000861	0.00342	CcSEcCtD
Phentermine—MAOA—kidney—kidney cancer	0.000859	0.0426	CbGeAlD
Phentermine—Oedema—Sunitinib—kidney cancer	0.000859	0.00341	CcSEcCtD
Phentermine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000856	0.0034	CcSEcCtD
Phentermine—Fatigue—Erlotinib—kidney cancer	0.000855	0.00339	CcSEcCtD
Phentermine—Constipation—Erlotinib—kidney cancer	0.000848	0.00337	CcSEcCtD
Phentermine—MAOA—cortex of kidney—kidney cancer	0.000837	0.0415	CbGeAlD
Phentermine—Vomiting—Pazopanib—kidney cancer	0.000828	0.00328	CcSEcCtD
Phentermine—Rash—Pazopanib—kidney cancer	0.000821	0.00326	CcSEcCtD
Phentermine—Nausea—Temsirolimus—kidney cancer	0.000821	0.00326	CcSEcCtD
Phentermine—Dermatitis—Pazopanib—kidney cancer	0.00082	0.00325	CcSEcCtD
Phentermine—Agitation—Vincristine—kidney cancer	0.000818	0.00324	CcSEcCtD
Phentermine—Abdominal pain—Vinblastine—kidney cancer	0.000816	0.00324	CcSEcCtD
Phentermine—Headache—Pazopanib—kidney cancer	0.000816	0.00324	CcSEcCtD
Phentermine—Oedema—Dactinomycin—kidney cancer	0.000813	0.00322	CcSEcCtD
Phentermine—Abdominal pain—Everolimus—kidney cancer	0.000813	0.00322	CcSEcCtD
Phentermine—Angina pectoris—Capecitabine—kidney cancer	0.000811	0.00322	CcSEcCtD
Phentermine—MAOA—cardiac atrium—kidney cancer	0.000796	0.0394	CbGeAlD
Phentermine—Dyspepsia—Sorafenib—kidney cancer	0.000786	0.00312	CcSEcCtD
Phentermine—Abdominal pain—Erlotinib—kidney cancer	0.000784	0.00311	CcSEcCtD
Phentermine—Insomnia—Sunitinib—kidney cancer	0.000777	0.00308	CcSEcCtD
Phentermine—Nausea—Pazopanib—kidney cancer	0.000773	0.00307	CcSEcCtD
Phentermine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00077	0.00306	CcSEcCtD
Phentermine—Fatigue—Sorafenib—kidney cancer	0.000769	0.00305	CcSEcCtD
Phentermine—Hypertension—Vincristine—kidney cancer	0.000768	0.00305	CcSEcCtD
Phentermine—Constipation—Sorafenib—kidney cancer	0.000763	0.00303	CcSEcCtD
Phentermine—Dyspepsia—Sunitinib—kidney cancer	0.000756	0.003	CcSEcCtD
Phentermine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000741	0.00294	CcSEcCtD
Phentermine—CYP1A2—renal system—kidney cancer	0.000741	0.0368	CbGeAlD
Phentermine—Asthenia—Vinblastine—kidney cancer	0.000741	0.00294	CcSEcCtD
Phentermine—Fatigue—Sunitinib—kidney cancer	0.00074	0.00294	CcSEcCtD
Phentermine—Asthenia—Everolimus—kidney cancer	0.000738	0.00293	CcSEcCtD
Phentermine—Constipation—Sunitinib—kidney cancer	0.000734	0.00291	CcSEcCtD
Phentermine—Acute coronary syndrome—Capecitabine—kidney cancer	0.000732	0.0029	CcSEcCtD
Phentermine—Hypertension—Gemcitabine—kidney cancer	0.000729	0.00289	CcSEcCtD
Phentermine—Myocardial infarction—Capecitabine—kidney cancer	0.000728	0.00289	CcSEcCtD
Phentermine—Oedema—Vincristine—kidney cancer	0.000726	0.00288	CcSEcCtD
Phentermine—Chest pain—Gemcitabine—kidney cancer	0.000719	0.00285	CcSEcCtD
Phentermine—Asthenia—Erlotinib—kidney cancer	0.000712	0.00282	CcSEcCtD
Phentermine—Urticaria—Sorafenib—kidney cancer	0.000709	0.00281	CcSEcCtD
Phentermine—Diarrhoea—Vinblastine—kidney cancer	0.000706	0.0028	CcSEcCtD
Phentermine—Abdominal pain—Sorafenib—kidney cancer	0.000706	0.0028	CcSEcCtD
Phentermine—Diarrhoea—Everolimus—kidney cancer	0.000703	0.00279	CcSEcCtD
Phentermine—Fatigue—Dactinomycin—kidney cancer	0.000701	0.00278	CcSEcCtD
Phentermine—Tension—Paclitaxel—kidney cancer	0.000694	0.00275	CcSEcCtD
Phentermine—Oedema—Gemcitabine—kidney cancer	0.000689	0.00273	CcSEcCtD
Phentermine—Nervousness—Paclitaxel—kidney cancer	0.000687	0.00272	CcSEcCtD
Phentermine—Dizziness—Vinblastine—kidney cancer	0.000683	0.00271	CcSEcCtD
Phentermine—Dizziness—Everolimus—kidney cancer	0.00068	0.0027	CcSEcCtD
Phentermine—Abdominal pain—Sunitinib—kidney cancer	0.000679	0.00269	CcSEcCtD
Phentermine—Diarrhoea—Erlotinib—kidney cancer	0.000679	0.00269	CcSEcCtD
Phentermine—Tremor—Paclitaxel—kidney cancer	0.000662	0.00263	CcSEcCtD
Phentermine—Insomnia—Vincristine—kidney cancer	0.000657	0.00261	CcSEcCtD
Phentermine—Vomiting—Vinblastine—kidney cancer	0.000656	0.0026	CcSEcCtD
Phentermine—Dizziness—Erlotinib—kidney cancer	0.000656	0.0026	CcSEcCtD
Phentermine—Vomiting—Everolimus—kidney cancer	0.000654	0.00259	CcSEcCtD
Phentermine—Agitation—Paclitaxel—kidney cancer	0.00065	0.00258	CcSEcCtD
Phentermine—Rash—Everolimus—kidney cancer	0.000648	0.00257	CcSEcCtD
Phentermine—Dermatitis—Everolimus—kidney cancer	0.000648	0.00257	CcSEcCtD
Phentermine—Headache—Vinblastine—kidney cancer	0.000647	0.00256	CcSEcCtD
Phentermine—Headache—Everolimus—kidney cancer	0.000644	0.00255	CcSEcCtD
Phentermine—Abdominal pain—Dactinomycin—kidney cancer	0.000643	0.00255	CcSEcCtD
Phentermine—Asthenia—Sorafenib—kidney cancer	0.00064	0.00254	CcSEcCtD
Phentermine—Cardiac failure—Doxorubicin—kidney cancer	0.000636	0.00252	CcSEcCtD
Phentermine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000634	0.00251	CcSEcCtD
Phentermine—Vomiting—Erlotinib—kidney cancer	0.000631	0.0025	CcSEcCtD
Phentermine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000627	0.00249	CcSEcCtD
Phentermine—Fatigue—Vincristine—kidney cancer	0.000626	0.00248	CcSEcCtD
Phentermine—Rash—Erlotinib—kidney cancer	0.000625	0.00248	CcSEcCtD
Phentermine—Dermatitis—Erlotinib—kidney cancer	0.000625	0.00248	CcSEcCtD
Phentermine—Palpitations—Paclitaxel—kidney cancer	0.000625	0.00248	CcSEcCtD
Phentermine—Insomnia—Gemcitabine—kidney cancer	0.000623	0.00247	CcSEcCtD
Phentermine—Headache—Erlotinib—kidney cancer	0.000621	0.00247	CcSEcCtD
Phentermine—Constipation—Vincristine—kidney cancer	0.000621	0.00246	CcSEcCtD
Phentermine—Asthenia—Sunitinib—kidney cancer	0.000616	0.00244	CcSEcCtD
Phentermine—Nausea—Vinblastine—kidney cancer	0.000613	0.00243	CcSEcCtD
Phentermine—Nausea—Everolimus—kidney cancer	0.000611	0.00242	CcSEcCtD
Phentermine—Diarrhoea—Sorafenib—kidney cancer	0.000611	0.00242	CcSEcCtD
Phentermine—Hypertension—Paclitaxel—kidney cancer	0.00061	0.00242	CcSEcCtD
Phentermine—Chest pain—Paclitaxel—kidney cancer	0.000602	0.00239	CcSEcCtD
Phentermine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000595	0.00236	CcSEcCtD
Phentermine—Fatigue—Gemcitabine—kidney cancer	0.000594	0.00236	CcSEcCtD
Phentermine—Cardiac arrest—Doxorubicin—kidney cancer	0.00059	0.00234	CcSEcCtD
Phentermine—Dizziness—Sorafenib—kidney cancer	0.00059	0.00234	CcSEcCtD
Phentermine—Constipation—Gemcitabine—kidney cancer	0.000589	0.00234	CcSEcCtD
Phentermine—Nausea—Erlotinib—kidney cancer	0.000589	0.00234	CcSEcCtD
Phentermine—Dry mouth—Paclitaxel—kidney cancer	0.000589	0.00233	CcSEcCtD
Phentermine—Diarrhoea—Sunitinib—kidney cancer	0.000588	0.00233	CcSEcCtD
Phentermine—Asthenia—Dactinomycin—kidney cancer	0.000583	0.00231	CcSEcCtD
Phentermine—Benzyl alcohol—CYP1A1—kidney cancer	0.00058	0.0696	CrCbGaD
Phentermine—Oedema—Paclitaxel—kidney cancer	0.000577	0.00229	CcSEcCtD
Phentermine—Abdominal pain—Vincristine—kidney cancer	0.000574	0.00228	CcSEcCtD
Phentermine—Dizziness—Sunitinib—kidney cancer	0.000568	0.00225	CcSEcCtD
Phentermine—Vomiting—Sorafenib—kidney cancer	0.000567	0.00225	CcSEcCtD
Phentermine—Tachycardia—Paclitaxel—kidney cancer	0.000563	0.00223	CcSEcCtD
Phentermine—Rash—Sorafenib—kidney cancer	0.000563	0.00223	CcSEcCtD
Phentermine—Dermatitis—Sorafenib—kidney cancer	0.000562	0.00223	CcSEcCtD
Phentermine—Headache—Sorafenib—kidney cancer	0.000559	0.00222	CcSEcCtD
Phentermine—Diarrhoea—Dactinomycin—kidney cancer	0.000556	0.00221	CcSEcCtD
Phentermine—Vomiting—Sunitinib—kidney cancer	0.000546	0.00217	CcSEcCtD
Phentermine—Tremor—Capecitabine—kidney cancer	0.000543	0.00216	CcSEcCtD
Phentermine—Rash—Sunitinib—kidney cancer	0.000541	0.00215	CcSEcCtD
Phentermine—Dermatitis—Sunitinib—kidney cancer	0.000541	0.00215	CcSEcCtD
Phentermine—Headache—Sunitinib—kidney cancer	0.000538	0.00213	CcSEcCtD
Phentermine—Nausea—Sorafenib—kidney cancer	0.00053	0.0021	CcSEcCtD
Phentermine—CYP2D6—renal system—kidney cancer	0.000528	0.0262	CbGeAlD
Phentermine—Angina pectoris—Doxorubicin—kidney cancer	0.000523	0.00207	CcSEcCtD
Phentermine—Insomnia—Paclitaxel—kidney cancer	0.000522	0.00207	CcSEcCtD
Phentermine—Asthenia—Vincristine—kidney cancer	0.000521	0.00207	CcSEcCtD
Phentermine—Vomiting—Dactinomycin—kidney cancer	0.000517	0.00205	CcSEcCtD
Phentermine—Palpitations—Capecitabine—kidney cancer	0.000513	0.00203	CcSEcCtD
Phentermine—Rash—Dactinomycin—kidney cancer	0.000513	0.00203	CcSEcCtD
Phentermine—CYP2D6—kidney—kidney cancer	0.000511	0.0253	CbGeAlD
Phentermine—Nausea—Sunitinib—kidney cancer	0.00051	0.00202	CcSEcCtD
Phentermine—Dyspepsia—Paclitaxel—kidney cancer	0.000508	0.00201	CcSEcCtD
Phentermine—Hypertension—Capecitabine—kidney cancer	0.000501	0.00199	CcSEcCtD
Phentermine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000498	0.00198	CcSEcCtD
Phentermine—Fatigue—Paclitaxel—kidney cancer	0.000497	0.00197	CcSEcCtD
Phentermine—Diarrhoea—Vincristine—kidney cancer	0.000497	0.00197	CcSEcCtD
Phentermine—Asthenia—Gemcitabine—kidney cancer	0.000494	0.00196	CcSEcCtD
Phentermine—Chest pain—Capecitabine—kidney cancer	0.000494	0.00196	CcSEcCtD
Phentermine—Constipation—Paclitaxel—kidney cancer	0.000493	0.00196	CcSEcCtD
Phentermine—Dry mouth—Capecitabine—kidney cancer	0.000483	0.00192	CcSEcCtD
Phentermine—Nausea—Dactinomycin—kidney cancer	0.000483	0.00192	CcSEcCtD
Phentermine—Dizziness—Vincristine—kidney cancer	0.00048	0.00191	CcSEcCtD
Phentermine—Oedema—Capecitabine—kidney cancer	0.000473	0.00188	CcSEcCtD
Phentermine—Diarrhoea—Gemcitabine—kidney cancer	0.000471	0.00187	CcSEcCtD
Phentermine—Tachycardia—Capecitabine—kidney cancer	0.000462	0.00183	CcSEcCtD
Phentermine—Vomiting—Vincristine—kidney cancer	0.000462	0.00183	CcSEcCtD
Phentermine—Urticaria—Paclitaxel—kidney cancer	0.000458	0.00182	CcSEcCtD
Phentermine—Rash—Vincristine—kidney cancer	0.000458	0.00182	CcSEcCtD
Phentermine—Dermatitis—Vincristine—kidney cancer	0.000458	0.00181	CcSEcCtD
Phentermine—Abdominal pain—Paclitaxel—kidney cancer	0.000456	0.00181	CcSEcCtD
Phentermine—Headache—Vincristine—kidney cancer	0.000455	0.0018	CcSEcCtD
Phentermine—Vomiting—Gemcitabine—kidney cancer	0.000438	0.00174	CcSEcCtD
Phentermine—Rash—Gemcitabine—kidney cancer	0.000434	0.00172	CcSEcCtD
Phentermine—Dermatitis—Gemcitabine—kidney cancer	0.000434	0.00172	CcSEcCtD
Phentermine—Headache—Gemcitabine—kidney cancer	0.000432	0.00171	CcSEcCtD
Phentermine—Nausea—Vincristine—kidney cancer	0.000431	0.00171	CcSEcCtD
Phentermine—Insomnia—Capecitabine—kidney cancer	0.000428	0.0017	CcSEcCtD
Phentermine—Dyspepsia—Capecitabine—kidney cancer	0.000417	0.00165	CcSEcCtD
Phentermine—Asthenia—Paclitaxel—kidney cancer	0.000414	0.00164	CcSEcCtD
Phentermine—Nausea—Gemcitabine—kidney cancer	0.000409	0.00162	CcSEcCtD
Phentermine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000409	0.00162	CcSEcCtD
Phentermine—Fatigue—Capecitabine—kidney cancer	0.000408	0.00162	CcSEcCtD
Phentermine—Constipation—Capecitabine—kidney cancer	0.000405	0.00161	CcSEcCtD
Phentermine—Diarrhoea—Paclitaxel—kidney cancer	0.000395	0.00157	CcSEcCtD
Phentermine—Dizziness—Paclitaxel—kidney cancer	0.000381	0.00151	CcSEcCtD
Phentermine—Urticaria—Capecitabine—kidney cancer	0.000376	0.00149	CcSEcCtD
Phentermine—Abdominal pain—Capecitabine—kidney cancer	0.000374	0.00148	CcSEcCtD
Phentermine—Tension—Doxorubicin—kidney cancer	0.000367	0.00146	CcSEcCtD
Phentermine—Vomiting—Paclitaxel—kidney cancer	0.000367	0.00146	CcSEcCtD
Phentermine—Rash—Paclitaxel—kidney cancer	0.000364	0.00144	CcSEcCtD
Phentermine—Dermatitis—Paclitaxel—kidney cancer	0.000363	0.00144	CcSEcCtD
Phentermine—Nervousness—Doxorubicin—kidney cancer	0.000363	0.00144	CcSEcCtD
Phentermine—Headache—Paclitaxel—kidney cancer	0.000361	0.00143	CcSEcCtD
Phentermine—Agitation—Doxorubicin—kidney cancer	0.000344	0.00136	CcSEcCtD
Phentermine—Nausea—Paclitaxel—kidney cancer	0.000343	0.00136	CcSEcCtD
Phentermine—Asthenia—Capecitabine—kidney cancer	0.00034	0.00135	CcSEcCtD
Phentermine—Palpitations—Doxorubicin—kidney cancer	0.00033	0.00131	CcSEcCtD
Phentermine—Diarrhoea—Capecitabine—kidney cancer	0.000324	0.00128	CcSEcCtD
Phentermine—Hypertension—Doxorubicin—kidney cancer	0.000323	0.00128	CcSEcCtD
Phentermine—Chest pain—Doxorubicin—kidney cancer	0.000318	0.00126	CcSEcCtD
Phentermine—Dizziness—Capecitabine—kidney cancer	0.000313	0.00124	CcSEcCtD
Phentermine—Dry mouth—Doxorubicin—kidney cancer	0.000311	0.00124	CcSEcCtD
Phentermine—Oedema—Doxorubicin—kidney cancer	0.000305	0.00121	CcSEcCtD
Phentermine—Vomiting—Capecitabine—kidney cancer	0.000301	0.00119	CcSEcCtD
Phentermine—Rash—Capecitabine—kidney cancer	0.000299	0.00118	CcSEcCtD
Phentermine—Dermatitis—Capecitabine—kidney cancer	0.000298	0.00118	CcSEcCtD
Phentermine—Tachycardia—Doxorubicin—kidney cancer	0.000298	0.00118	CcSEcCtD
Phentermine—Headache—Capecitabine—kidney cancer	0.000297	0.00118	CcSEcCtD
Phentermine—Selegiline—ABCB1—kidney cancer	0.000296	0.0355	CrCbGaD
Phentermine—Nausea—Capecitabine—kidney cancer	0.000281	0.00112	CcSEcCtD
Phentermine—Insomnia—Doxorubicin—kidney cancer	0.000276	0.00109	CcSEcCtD
Phentermine—Dyspepsia—Doxorubicin—kidney cancer	0.000269	0.00107	CcSEcCtD
Phentermine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000263	0.00105	CcSEcCtD
Phentermine—Fatigue—Doxorubicin—kidney cancer	0.000263	0.00104	CcSEcCtD
Phentermine—Constipation—Doxorubicin—kidney cancer	0.000261	0.00104	CcSEcCtD
Phentermine—Urticaria—Doxorubicin—kidney cancer	0.000242	0.000962	CcSEcCtD
Phentermine—Abdominal pain—Doxorubicin—kidney cancer	0.000241	0.000957	CcSEcCtD
Phentermine—Asthenia—Doxorubicin—kidney cancer	0.000219	0.000869	CcSEcCtD
Phentermine—Diarrhoea—Doxorubicin—kidney cancer	0.000209	0.000828	CcSEcCtD
Phentermine—Dizziness—Doxorubicin—kidney cancer	0.000202	0.000801	CcSEcCtD
Phentermine—Vomiting—Doxorubicin—kidney cancer	0.000194	0.00077	CcSEcCtD
Phentermine—Rash—Doxorubicin—kidney cancer	0.000192	0.000763	CcSEcCtD
Phentermine—Dermatitis—Doxorubicin—kidney cancer	0.000192	0.000763	CcSEcCtD
Phentermine—Headache—Doxorubicin—kidney cancer	0.000191	0.000758	CcSEcCtD
Phentermine—Nausea—Doxorubicin—kidney cancer	0.000181	0.000719	CcSEcCtD
Phentermine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	0.000126	0.0012	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTT1—kidney cancer	0.000124	0.00119	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000123	0.00118	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CCBL1—kidney cancer	0.000122	0.00118	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000122	0.00117	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000121	0.00116	CbGpPWpGaD
Phentermine—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	0.00012	0.00115	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	0.000118	0.00113	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—PTGS1—kidney cancer	0.000117	0.00112	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	0.000116	0.00111	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000114	0.00109	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000113	0.00109	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000113	0.00108	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000111	0.00107	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.00011	0.00105	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CA9—kidney cancer	0.000109	0.00105	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000108	0.00103	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000106	0.00102	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTT1—kidney cancer	0.000106	0.00102	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GLIPR1—kidney cancer	0.000106	0.00102	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PPAT—kidney cancer	0.000106	0.00102	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000106	0.00101	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000105	0.00101	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000104	0.000997	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000104	0.000997	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000103	0.000987	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000103	0.000985	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.000102	0.000976	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000101	0.000969	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—JUN—kidney cancer	0.000101	0.000965	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.0001	0.000962	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—PTGS1—kidney cancer	9.97e-05	0.000957	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	9.89e-05	0.000949	CbGpPWpGaD
Phentermine—MAOA—Metabolism—FH—kidney cancer	9.87e-05	0.000947	CbGpPWpGaD
Phentermine—MAOA—Metabolism—APRT—kidney cancer	9.87e-05	0.000947	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—PTEN—kidney cancer	9.73e-05	0.000934	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.51e-05	0.000912	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—RAF1—kidney cancer	9.49e-05	0.000911	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GPC3—kidney cancer	9.28e-05	0.000891	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CRABP1—kidney cancer	9.27e-05	0.00089	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.18e-05	0.000881	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CA2—kidney cancer	9.03e-05	0.000866	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.01e-05	0.000865	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—VEGFA—kidney cancer	8.82e-05	0.000846	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—RAF1—kidney cancer	8.82e-05	0.000846	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ALAD—kidney cancer	8.8e-05	0.000844	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.79e-05	0.000844	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—BRAF—kidney cancer	8.71e-05	0.000836	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	8.7e-05	0.000835	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.64e-05	0.000829	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTP1—kidney cancer	8.63e-05	0.000828	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ITPR2—kidney cancer	8.62e-05	0.000827	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ST3GAL2—kidney cancer	8.59e-05	0.000824	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	8.58e-05	0.000824	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	8.51e-05	0.000817	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.42e-05	0.000808	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ALDH1A1—kidney cancer	8.39e-05	0.000805	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.13e-05	0.000781	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—BRAF—kidney cancer	8.09e-05	0.000777	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PGK1—kidney cancer	8.05e-05	0.000772	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SLC5A3—kidney cancer	8.05e-05	0.000772	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	8e-05	0.000768	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.95e-05	0.000763	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTM1—kidney cancer	7.93e-05	0.000761	CbGpPWpGaD
Phentermine—MAOA—Metabolism—LDHB—kidney cancer	7.89e-05	0.000757	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	7.89e-05	0.000757	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTT1—kidney cancer	7.86e-05	0.000754	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ACHE—kidney cancer	7.86e-05	0.000754	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	7.82e-05	0.00075	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.78e-05	0.000746	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	7.58e-05	0.000728	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	7.52e-05	0.000721	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	7.48e-05	0.000718	CbGpPWpGaD
Phentermine—MAOB—Metabolism—SCARB1—kidney cancer	7.44e-05	0.000714	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	7.41e-05	0.000711	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTP1—kidney cancer	7.37e-05	0.000708	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PTGS1—kidney cancer	7.37e-05	0.000707	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	7.35e-05	0.000705	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	7.27e-05	0.000698	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—RAF1—kidney cancer	7.27e-05	0.000698	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.25e-05	0.000696	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PSMD7—kidney cancer	7.22e-05	0.000693	CbGpPWpGaD
Phentermine—MAOB—Metabolism—BCHE—kidney cancer	6.85e-05	0.000657	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CA9—kidney cancer	6.84e-05	0.000657	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTM1—kidney cancer	6.78e-05	0.00065	CbGpPWpGaD
Phentermine—MAOB—Metabolism—SLC5A5—kidney cancer	6.76e-05	0.000649	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—RAF1—kidney cancer	6.76e-05	0.000648	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	6.68e-05	0.000641	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ACY1—kidney cancer	6.67e-05	0.00064	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TP53—kidney cancer	6.64e-05	0.000637	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ACY1—kidney cancer	6.61e-05	0.000634	CbGpPWpGaD
Phentermine—MAOB—Metabolism—SLC2A1—kidney cancer	6.53e-05	0.000627	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.51e-05	0.000625	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	6.42e-05	0.000616	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.42e-05	0.000616	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	6.33e-05	0.000608	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.05e-05	0.00058	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CRABP1—kidney cancer	5.82e-05	0.000558	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PDHB—kidney cancer	5.67e-05	0.000544	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—POMC—kidney cancer	5.65e-05	0.000542	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ACY1—kidney cancer	5.65e-05	0.000542	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.64e-05	0.000541	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PDHB—kidney cancer	5.62e-05	0.000539	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—POMC—kidney cancer	5.6e-05	0.000538	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTP1—kidney cancer	5.45e-05	0.000523	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ITPR2—kidney cancer	5.41e-05	0.000519	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CCBL1—kidney cancer	5.33e-05	0.000512	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CCBL1—kidney cancer	5.29e-05	0.000507	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ABCB1—kidney cancer	5.16e-05	0.000495	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTM1—kidney cancer	5.01e-05	0.00048	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—MAPK1—kidney cancer	4.99e-05	0.000479	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTT1—kidney cancer	4.93e-05	0.000473	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ACHE—kidney cancer	4.93e-05	0.000473	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.82e-05	0.000462	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PDHB—kidney cancer	4.8e-05	0.000461	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—POMC—kidney cancer	4.79e-05	0.00046	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.78e-05	0.000459	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP1A1—kidney cancer	4.75e-05	0.000455	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SCARB1—kidney cancer	4.67e-05	0.000448	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—MAPK1—kidney cancer	4.63e-05	0.000445	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PPAT—kidney cancer	4.62e-05	0.000444	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GLIPR1—kidney cancer	4.62e-05	0.000444	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PTGS1—kidney cancer	4.62e-05	0.000444	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.58e-05	0.00044	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PPAT—kidney cancer	4.58e-05	0.00044	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PSMD7—kidney cancer	4.53e-05	0.000435	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.52e-05	0.000434	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CCBL1—kidney cancer	4.52e-05	0.000433	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.48e-05	0.00043	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—FH—kidney cancer	4.3e-05	0.000412	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—APRT—kidney cancer	4.3e-05	0.000412	CbGpPWpGaD
Phentermine—MAOA—Metabolism—BCHE—kidney cancer	4.3e-05	0.000412	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—FH—kidney cancer	4.26e-05	0.000409	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—APRT—kidney cancer	4.26e-05	0.000409	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SLC5A5—kidney cancer	4.24e-05	0.000407	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.16e-05	0.0004	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	4.1e-05	0.000394	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SLC2A1—kidney cancer	4.1e-05	0.000393	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.08e-05	0.000392	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GPC3—kidney cancer	4.04e-05	0.000388	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GPC3—kidney cancer	4.01e-05	0.000384	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CA2—kidney cancer	3.93e-05	0.000377	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.92e-05	0.000376	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PPAT—kidney cancer	3.92e-05	0.000376	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CA2—kidney cancer	3.9e-05	0.000374	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.87e-05	0.000371	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ALAD—kidney cancer	3.83e-05	0.000368	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.83e-05	0.000367	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ALAD—kidney cancer	3.8e-05	0.000364	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	3.74e-05	0.000359	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.71e-05	0.000356	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	3.65e-05	0.000351	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—APRT—kidney cancer	3.64e-05	0.000349	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—FH—kidney cancer	3.64e-05	0.000349	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.63e-05	0.000349	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.62e-05	0.000348	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.56e-05	0.000341	CbGpPWpGaD
Phentermine—MAOB—Metabolism—POMC—kidney cancer	3.54e-05	0.00034	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SLC5A3—kidney cancer	3.5e-05	0.000336	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PGK1—kidney cancer	3.5e-05	0.000336	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.47e-05	0.000333	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PGK1—kidney cancer	3.47e-05	0.000333	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—LDHB—kidney cancer	3.44e-05	0.00033	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GPC3—kidney cancer	3.42e-05	0.000328	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTP1—kidney cancer	3.42e-05	0.000328	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—LDHB—kidney cancer	3.41e-05	0.000327	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CA2—kidney cancer	3.33e-05	0.00032	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ALAD—kidney cancer	3.24e-05	0.000311	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ABCB1—kidney cancer	3.24e-05	0.000311	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	3.17e-05	0.000304	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTM1—kidney cancer	3.14e-05	0.000301	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	3.1e-05	0.000297	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CA9—kidney cancer	2.98e-05	0.000286	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP1A1—kidney cancer	2.98e-05	0.000286	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.97e-05	0.000285	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PGK1—kidney cancer	2.97e-05	0.000285	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CA9—kidney cancer	2.95e-05	0.000283	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—LDHB—kidney cancer	2.91e-05	0.000279	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.89e-05	0.000277	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PTGS2—kidney cancer	2.82e-05	0.000271	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CRABP1—kidney cancer	2.53e-05	0.000243	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CA9—kidney cancer	2.52e-05	0.000242	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CRABP1—kidney cancer	2.51e-05	0.000241	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.47e-05	0.000237	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PTEN—kidney cancer	2.46e-05	0.000236	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ITPR2—kidney cancer	2.35e-05	0.000226	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ITPR2—kidney cancer	2.33e-05	0.000224	CbGpPWpGaD
Phentermine—MAOA—Metabolism—POMC—kidney cancer	2.22e-05	0.000213	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.15e-05	0.000207	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTT1—kidney cancer	2.15e-05	0.000206	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ACHE—kidney cancer	2.15e-05	0.000206	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CRABP1—kidney cancer	2.15e-05	0.000206	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ACHE—kidney cancer	2.13e-05	0.000204	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTT1—kidney cancer	2.13e-05	0.000204	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SCARB1—kidney cancer	2.03e-05	0.000195	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SCARB1—kidney cancer	2.01e-05	0.000193	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PTGS1—kidney cancer	2.01e-05	0.000193	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ITPR2—kidney cancer	1.99e-05	0.000191	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PTGS1—kidney cancer	1.99e-05	0.000191	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.97e-05	0.000189	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PSMD7—kidney cancer	1.96e-05	0.000188	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—BCHE—kidney cancer	1.87e-05	0.00018	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—BCHE—kidney cancer	1.85e-05	0.000178	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.85e-05	0.000177	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.84e-05	0.000176	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.83e-05	0.000176	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTT1—kidney cancer	1.82e-05	0.000175	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ACHE—kidney cancer	1.82e-05	0.000175	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.78e-05	0.000171	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PTGS2—kidney cancer	1.77e-05	0.00017	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.77e-05	0.00017	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PIK3CA—kidney cancer	1.74e-05	0.000167	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SCARB1—kidney cancer	1.72e-05	0.000165	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.72e-05	0.000165	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PTGS1—kidney cancer	1.7e-05	0.000164	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PSMD7—kidney cancer	1.67e-05	0.00016	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—BCHE—kidney cancer	1.58e-05	0.000152	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.57e-05	0.00015	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PTEN—kidney cancer	1.54e-05	0.000148	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.51e-05	0.000145	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.5e-05	0.000144	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.49e-05	0.000143	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTP1—kidney cancer	1.48e-05	0.000142	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.47e-05	0.000141	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ABCB1—kidney cancer	1.41e-05	0.000135	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ABCB1—kidney cancer	1.4e-05	0.000134	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTM1—kidney cancer	1.37e-05	0.000131	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTM1—kidney cancer	1.36e-05	0.00013	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.3e-05	0.000124	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.29e-05	0.000123	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.28e-05	0.000123	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTP1—kidney cancer	1.26e-05	0.000121	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ABCB1—kidney cancer	1.19e-05	0.000115	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTM1—kidney cancer	1.16e-05	0.000111	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.1e-05	0.000105	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PIK3CA—kidney cancer	1.09e-05	0.000105	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.06e-05	0.000101	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—POMC—kidney cancer	9.67e-06	9.28e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—POMC—kidney cancer	9.58e-06	9.2e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.02e-06	8.66e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—POMC—kidney cancer	8.19e-06	7.86e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PTGS2—kidney cancer	7.71e-06	7.4e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PTGS2—kidney cancer	7.64e-06	7.34e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PTEN—kidney cancer	6.72e-06	6.45e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PTEN—kidney cancer	6.67e-06	6.4e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PTGS2—kidney cancer	6.53e-06	6.27e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PTEN—kidney cancer	5.7e-06	5.47e-05	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PIK3CA—kidney cancer	4.74e-06	4.55e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.7e-06	4.51e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PIK3CA—kidney cancer	4.02e-06	3.86e-05	CbGpPWpGaD
